Gallbladder cancer: South American experience

Chinese Clinical Oncology

Volumn 5, Issue 5, 2016, Pages

  Arroyo, Gerardo F ^a   Gentile, Alberto ^b   Parada, Luis A ^c  

^a ILOGI (Latin American Gastrointestinal Oncology Intergroup)   (Argentina)

^b Department of Epidemiology   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Epidemiology; Gallbladder cancer (GBC); Genetic abnormalities; Pathogenesis; South America

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL (TOPIC); GALLBLADDER CANCER; HUMAN; MOLECULAR PATHOLOGY; REVIEW; SOUTH AMERICAN; FEMALE; GALLBLADDER NEOPLASMS; GENETICS; PATHOLOGY; SOUTH AMERICA;

FEMALE; GALLBLADDER NEOPLASMS; HUMANS; SOUTH AMERICA;

EID: 84998880860     PISSN: 23043865     EISSN: 23043873     Source Type: Journal    
DOI: 10.21037/cco.2016.10.01     Document Type: Review

References (67)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013. Available online: http://globocan.iarc.fr, accessed on day/month/year
2. Abriata GM, Roques LF, Macías G, et al. Cancer Mortality Atlas. Argentina. 2007-2011. Instituto Nacional del Cáncer. Ministerio de Salud de la Natión. Available online: http://www.msal.gov.ar/inc/images/stories/downloads/publicaciones/29-Atlas-de-mortalidadopt.pdf
3. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review 1975-2012, National Cancer Institute. Bethesda, MD. Available online: http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015.
4. Principales causas de muerte según región, sexo y año de defunción. Departamento de Estadísticas e Información de Salud (DEIS) Chile, 2000-2012. Available online: http://www.deis.cl/?p=2541
5. Atlas on Line 2014. Instituto Nacional del Cáncer, José Alencar Gomes Da Silva. Available online: https://mortalidade.inca.gov.br/
6. Barrios E, Alonso R, Garau M, Musetti C. Situatión epidemiológica del Uruguay en relatión al cancáer. Registro Nacional de Cáncer, Comisión Honoraria de Lucha Contra el Cáncer. 2014. Available online: http://www.comisioncancer.org.uy/categoria_53_1.html
7. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents, Vol. IX. Lyon: IARC, 2007. Available online: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/
8. Instituto Nacional de Estadísticas y Censos. Población. Available online: http://www.indec.gov.ar/nivel2_default.asp?seccion=P&id_tema=2
9. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelitiasis and cancer. Gut Liver 2012;6:172-87.
10. Báez S, Tsuchiya Y, Calvo A, et al. Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women. World J Gastroenterol 2010;16:372-8.
11. Strom BL, Soloway RD, Rios-Dalenz JL, et al. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer 1995;76:1747-56.
12. Nagaraja V, Eslick GD. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther 2014;39:745-50.
13. Rai R, Sharma KL, Misra S, et al. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females. Gene 2013;530:172-7.
14. Serra I, Yamamoto M, Calvo C, et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a chilean population. Int J Cancer 2002;102:407-411.
15. Tsuchiya Y, Terao M, Okano K, et al. Mutagenicity and mutagen of the red chili pepper as gallbladder cancer risk factor in chilean women. Asian Pac J Cancer Prev 2011;12:471-6.
16. Asai T, Tsuchiya Y, Okano K, et al. Anatoxin contamination of red chili pepper from Bolivia and Peru, countries with high gallbladder cancer incidence rates. Asian Pac J Cancer Prev 2012;13:5167-70.
17. Nogueira L, Foerster C, Groopman J, et al. Association of aflatoxin with gallbladder cancer in Chile. JAMA 2015;313:2075-7.
18. Welton JC, Marr JS, Friedman SM. Association between hepatobiliary cancer and typhoid carrier state. Lancet 1979;1:791-4.
19. Pandey M, Shukla VK. Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer. Eur J Cancer Prev 2003;12:269-72.
20. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991;87:237-46.
21. Censo de Población y Vivienda. Instituto nacional de estadísticas y censos (INDEC). Argentina 2010. Available online: http://www.censo2010.indec.gov.ar/novedades/novedades_detalle.asp?id=20983
22. Government from Chile. Informe de la Comisión Verdad Histórica y Nuevo Trato con los Pueblos Indígenas. Presidential Commitee for Native People Affairs (ed). First edition, Santiago de Chile, 2008. Available online: http://www.corteidh.or.cr/tablas/27374.pdf
23. Schlebusch CM, Gattepaille LM, Engström K, et al. Human Adaptation to arsenic-rich environments. Mol Biol Evol 2015;32:1544-55.
24. Pandey M. Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev 2003;12:15-24.
25. Mathur SK, Duhan A, Singh S, et al. Correlation of gallstone characteristics with mucosal changes in gall bladder. Trop Gastroenterol 2012;33:39-44.
26. López-Carrillo L, Hernández Avila M, et al. Chili pepper consumption and gastric cáncer in Mexico: a case-control study. Am J Epidemiol 1994;139:263-71.
27. Archer VE, Jones DW. Capsaicin pepper, cancer and ethnicity. Med Hypotheses 2002;59:450-7.
28. Ghadirian P, Ekoé JM, Thouez JP. Food habits and esophageal cancer: an overview. Cancer Detect Prev1992;16:163-8.
29. Matsuba T, Qiu D, Kurosawa M, et al. JACC Study Group. Overview of epidemiology of bile duct and gallbladder cancer focusing on the JACC Study. J Epidemiol 2005;15 Suppl 2:S150-6.
30. Castillo J, García P, Roa J. Alteraciones genéticas en lesiones preneoplásicas y neoplásicas de la vesícula biliar. Rev Med Chile 2010;138:595-604.
31. Parada LA, Hallén M, Tranberg KG, et al. Frequent rearrangements of chromosomes 1, 7, and 8 in primary liver cancer. Genes Chromosomes Cancer 1998;23:26-35.
32. Gorunova L, Parada LA, Limon J, et al. Nonrandom chromosomal aberrations and cytogenetic heterogeneity in gallbladder carcinomas. Genes Chromosomes Cancer 1999;26:312-21.
33. Pai RK, Mojtahed K, Pai RK. Mutations in the RAS/ RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas. Appl Immunohistochem Mol Morphol 2011;19:133-40.
34. Asai T, Loza E, Roig GV, et al. High frequency of TP53 but not K-ras gene mutations in Bolivian patients with gallbladder cancer. Asian Pac J Cancer Prev 2014;15:5449-54.
35. Wistuba II, Sugio K, Hung J, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995;55:2511-5.
36. Kim YT, Kim J, Jang YH, et al. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett 2001;169:59-68.
37. Roa JC, Anabalón L, Roa I, et al. Promoter methylation profile in gallbladder cancer. J Gastroenterol 2006;41:269-75.
38. Chan E, Berlin J. Biliary tract cancers: understudied and poorly understood. J Clin Oncol 2015;33:1845-8.
39. Yokoyama N, Hitomi J, Watanabe H, et al. Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol Biomarkers Prev 1998;7:297-301.
40. Roa I, de Aretxabala X, Fuentealba P, et al. DNA content and survival in subserous gallbladder carcinoma. Rev Med Chile 2004;132:794-800.
41. Kazmi HR, Chandra A, Nigam J, et al. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer. Dig Surg 2013; 30:233-9.
42. Arroyo GF, Acosta G, Monteros Alvi M, et al. Prevalence of KIT expression in human tumors: gallbladder cancer. J Clin Oncol 2005;23:5268-71; author reply 5271-2.
43. Aswad B, Constantinou M, Iannitti D. KIT is a potential therapeutic target for biliary carcinomas. Proc Am Soc Clin Oncol 2002;21:103.
44. Roa JC, Roa L, Correa P, et al. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder. J Gastroenterol 2005;40:79-86.
45. Saetta AA. K-ras, p53 Mutations, and Microsatellite Instability (MSI) in Gallbladder Cancer. J Surg Oncol 2006;93:644-9.
46. Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch repair deficiency. The New Engl J Med 2015;372:2509-20.
47. Arroyo GF, Kaen D, Salvatierra A, et al. F-box and WD repeat domain-containing 7 (FBXW7) mRNA and outcome in biliary tract cancer. J Clin Oncol 2012;30:abstr e14521.
48. Akhoondi S, Sun D, von der Lehr N, et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007;67:9006-12.
49. Manterola C, Vial M, Roa JC. Survival of a cohort of patients with intermediate and advanced gall bladder cancer treated with a prospective therapeutic protocol. Acta Cir Bras 2010;25:225-30.
50. Lendoire JC, Gil L, Duek F, et al. Relevance of residual disease after liver resection for incidental gallbladder cancer. HPB (Oxford) 2012;14:548-53.
51. González M, Silva S, Folch P, et al. Radio-quimioterapia adyuvante en pacientes con cancer de vesícula biliar: experiencia Institute) Oncológico-Viña del Mar, Chile. Latinamerican Symposium of Oncologic Gastroenterology (SLAGO) 2015 Oral presentation.
52. Gallardo JO, Rubio B, Fodor M et al. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol 2001;12:1403-06.
53. Reyes-Vidal JM, Gallardo J, Yanez E, et al. Gemcitabine (Gem) and cisplatin (CIS) in the treatment of patients (pts) with unresectable or metastatic gallbladder cancer: results of the phase II GOCCHI study 2000-13. Proc Am Soc Clin Oncol 2003;22:abstr 1095.
54. Carraro S, Servienti PJ, Bruno MF, et al. Gemcitabine and cisplatin in locally advanced or metastatic gallbladder and bile duct adenocarcinomas. Proc Am Soc Clin Oncol 2001;20:abstr 2333.
55. Arroyo G, Carballido M, Kaen D, et al. Cholangiocarcinoma (C) and gallbladder cancer (G): two different diseases. Analysis of 173 patients. Ann Oncol 2010;21:P 0259.
56. Bartlett DL, Fong Y, Fortner JG, et al. Long term results after resection for gallbladder cancer: implications for staging and management. Ann Surg 1996;224:639-46.
57. Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 1996;120:816-21.
58. Sobin LH, Gospodarowicz MK, Wittekind C. editors. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. 7th ed. Hoboken, NJ: Wiley-Blackwell, 2010.
59. Horgan AM, Amir E, Walter T, et al. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol 2012;30:1934-40.
60. Bartlett DL, Ramanthan RK, Ben-Josef E. Cancer of the Biliary Tree. In: DeVita VT, Lawrence TS, Rosenberg SA. editors. Cancer Principles and Practice of Oncology. 8th edition. Philadelphia: Lippincott Williams and Wilkins, 2008:1156-86.
61. Eckel F, Schmid RM. CHT in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 2007;96:896-902.
62. Valle J. Wasan H, Palmer DH. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer. N Engl J Med 2010;362:1273-81.
63. Ross JS, Wang K, Javle MM, et al. Comprehensive genomic profiling of biliary tract cancers to reveal tumor-specific differences and frequency of clinical relevant genomic alterations. J Clin Oncol 2015;33:abstr 4009.
64. Sauri T, Macarulla T, Cabrera G, et al. Comprehensive profiling of biliary tract cancers (BTC) to reveal molecular heterogeneity with implications for matched targeted therapies (MTT). J Clin Oncol 2016;34:abstr 4085.
65. Colecistectomía preventiva en adultos de 35 a 49 años. Guía Clínica. Ministerio de Salud. Gobierno de Chile. Available online: http://web.minsal.cl/portal/url/item/72205a1420599f92e04001011f016d02.pdf
66. Rege RV. Asymptomatic Gallstones. In: Bland KI, Sarr MG, Buchler MW, et al. editors. General Surgery: Principles and International Practice. London: Springer, 2009:1035-40.
67. Arroyo GF, Gentile A, Parada LA. Gallbladder cancer: south american experience. Chin Clin Oncol 2016;5(5):67. doi: 10.21037/cco.2016.10.01